Who
Lloyd Minor
Director
Company insider
Files Form 4 as: Director, Caris Life Sciences; Director, Biogen.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 2
- Bought
- $0
- Sold
- $480K
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 17 Jun 2025
- Last trade
- 14 Aug 2026
- Last filed
- 14 Aug 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Aug 2026filed 14 Aug 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | —13,192 at $0.00 | filing |
| 14 Aug 2026filed 14 Aug 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | —13,192 at $0.00 | filing |
| 4 Aug 2026filed 5 Aug 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Sold | $119K593 at $200.96 | filing |
| 4 Aug 2026filed 5 Aug 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Sold | $119K593 at $200.96 | filing |
| 3 Aug 2026filed 5 Aug 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Sold | $121K593 at $203.34 | filing |
| 3 Aug 2026filed 5 Aug 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Sold | $121K593 at $203.34 | filing |
| 9 Jun 2026filed 11 Jun 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code A | —1,505 at $0.00 | filing |
| 9 Jun 2026filed 11 Jun 2026 | BIIB BiogenBiotechnology | SEC FORM 4 Code A | —1,505 at $0.00 | filing |
| 26 Feb 2026filed 2 Mar 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | $50K2,492 at $20.06 | filing |
| 26 Feb 2026filed 2 Mar 2026 | CAI Caris Life SciencesDiagnostics & Labs | SEC FORM 4 Code A | $50K2,492 at $20.06 | filing |
| 17 Jun 2025filed 18 Jun 2025 | BIIB BiogenBiotechnology | SEC FORM 4 Code A | —2,370 at $0.00 | filing |
News
Biogen (NASDAQ:BIIB) Hits New 52-Week High Following Analyst UpgradeBIIB · dailypolitical.com · 14 Oct 2026Biogen (BIIB) vs Amgen (AMGN) and Gilead (GILD): Which Big Pharma Stock is a Better Buy?BIIB · insidermonkey.com · 13 Oct 2026
0 headlines in the last 90 days name Lloyd Minor; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.